Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A N Vis

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Onkologie|September 16, 2003
Recurrence after radical prostatectomy for organ-confined prostate cancerJ R Scheepe, A N Vis, G H Mickisch
Microscopy Research and Technique|November 14, 2000
Staging prostate cancerR F Hoedemaeker, A N Vis, T H Van Der Kwast
Molecular Urology|January 16, 2002
Feasibility of assessment of promoter methylation of the CD44 gene in serum of prostate cancer patientsA N Vis, M Oomen, F H Schröder, et al.
American Journal of Clinical Pathology|March 8, 2000
Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sectionsA N Vis, R Kranse, A L Nigg, et al.
The Prostate|February 15, 2001
Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification modelA N Vis, R F Hoedemaeker, T H van der Kwast, et al.
Urology|February 13, 2001
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examinationF H Schröder, M Roobol-Bouts, A N Vis, et al.
BJU International|March 2, 2002
Serendipity in detecting disease in low prostate-specific antigen rangesA N Vis, R Kranse, M Roobol, et al.
Journal of Robotic Surgery|April 3, 2021
Preoperative multiparametric MRI does not lower positive surgical margin rate in a large series of patients undergoing robot-assisted radical prostatectomyL Gietelink, B H E Jansen, D E Oprea-Lager, et al.
The Prostate|June 9, 2001
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml)A N Vis, R F Hoedemaeker, M Roobol, et al.
Cancer|August 16, 2001
The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancerA N Vis, R F Hoedemaeker, M Roobol, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Onkologie|September 16, 2003
Recurrence after radical prostatectomy for organ-confined prostate cancerJ R Scheepe, A N Vis, G H Mickisch
Microscopy Research and Technique|November 14, 2000
Staging prostate cancerR F Hoedemaeker, A N Vis, T H Van Der Kwast
Molecular Urology|January 16, 2002
Feasibility of assessment of promoter methylation of the CD44 gene in serum of prostate cancer patientsA N Vis, M Oomen, F H Schröder, et al.
American Journal of Clinical Pathology|March 8, 2000
Quantitative analysis of the decay of immunoreactivity in stored prostate needle biopsy sectionsA N Vis, R Kranse, A L Nigg, et al.
The Prostate|February 15, 2001
Defining the window of opportunity in screening for prostate cancer: validation of a predictive tumor classification modelA N Vis, R F Hoedemaeker, T H van der Kwast, et al.
Urology|February 13, 2001
Prostate-specific antigen-based early detection of prostate cancer--validation of screening without rectal examinationF H Schröder, M Roobol-Bouts, A N Vis, et al.
BJU International|March 2, 2002
Serendipity in detecting disease in low prostate-specific antigen rangesA N Vis, R Kranse, M Roobol, et al.
Journal of Robotic Surgery|April 3, 2021
Preoperative multiparametric MRI does not lower positive surgical margin rate in a large series of patients undergoing robot-assisted radical prostatectomyL Gietelink, B H E Jansen, D E Oprea-Lager, et al.
The Prostate|June 9, 2001
Tumor characteristics in screening for prostate cancer with and without rectal examination as an initial screening test at low PSA (0.0-3.9 ng/ml)A N Vis, R F Hoedemaeker, M Roobol, et al.
Cancer|August 16, 2001
The predictive value for prostate cancer of lesions that raise suspicion of concomitant carcinoma: an evaluation from a randomized, population-based study of screening for prostate cancerA N Vis, R F Hoedemaeker, M Roobol, et al.
Pageof 4